Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictors of response to montelukast in childhood asthma
2005-004115-29Phase 4Active
- Sponsor
- Research Institute for the Prevention of Allergy and Airway Diseases in Childhood
- Start
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of montelukast in asthma, sponsored by Research Institute for the Prevention of Allergy and Airway Diseases in Childhood. Primary endpoint: Proportion of patients with FEV1 increase <5% or >5% after montelukast. Started Sep 2005; status: active.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-004115-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004115-29.